HOOKIPA Pharma | 4:持股变动声明-董事 Peters Malte
HOOKIPA Pharma | 4:持股变动声明-董事 Kaufman David Ross
HOOKIPA Pharma | 4:持股变动声明-董事 Reilly Timothy P.
HOOKIPA Pharma | 4:持股变动声明-董事 Coelho Mary Theresa
HOOKIPA Pharma | 4:持股变动声明-董事 O'Neill Julie
HOOKIPA Pharma | SC 13D:超过5%持股股东披露文件-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%)等
HOOKIPA Pharma | SC 13G:超过5%持股股东披露文件-EcoR1 Capital, LLC(5.9%),Oleg Nodelman(5.9%)等
HOOKIPA Pharma | 4:持股变动声明-高管 Necina Roman
HOOKIPA Pharma | 4:持股变动声明-高管 Orlinger Klaus
HOOKIPA Pharma | 4:持股变动声明-高管 Aldag Jorn
HOOKIPA Pharma | 4:持股变动声明-高管 Winderlich Mark
HOOKIPA Pharma | 4:持股变动声明-高管 Kandera Reinhard
HOOKIPA Pharma | 3:首次持股声明-高管 Winderlich Mark
HOOKIPA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-EcoR1 Capital, LLC(4.8%),Oleg Nodelman(4.8%)等
HOOKIPA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%)等
HOOKIPA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(1.1%),Jeremy C. Green(1.1%)
HOOKIPA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Gilead Sciences, Inc.(19.4%)
HOOKIPA Pharma | 3:首次持股声明-股东 GILEAD SCIENCES, INC.
HOOKIPA Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(4.118%),Abigail P. Johnson(4.118%)
HOOKIPA Pharma | 4:持股变动声明-首席财务官 Kandera Reinhard
暂无数据